{"slug":"nad-plus-tendon","verification":{"valid":true,"entries":2,"head":"e4a05dd48ea6905a41b10de749040a16d7bc3d8a9bd3e12d2b92b68852be0ad7"},"energy":{"passes":2,"tokens_in":29027,"tokens_out":2583,"tokens_total":31610,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"e4a05dd48ea6905a41b10de749040a16d7bc3d8a9bd3e12d2b92b68852be0ad7"},"provenance":[{"ts":"2026-06-30T01:41:04.867Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: NAD Plus for Tendon\nSlug: nad-plus-tendon\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"nad-plus\",\"name\":\"NAD+\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"nad-plus\",\"name\":\"NAD+\",\"section_title\":\"Why NAD+ might help you\",\"layer\":\"cellular energy\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **NAD+** → cellular energy\",\"section_headings\":[\"What's breaking down\",\"Why NAD+ might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide_chains / drug_chain","response":"{\n  \"slug\": \"nad-plus-tendon\",\n  \"title\": \"NAD+ for Tendon Issues: Evidence Review\",\n  \"body\": \"## What's breaking down\\n\\nTendon problems often involve layers of cellular energy decline, oxidative stress, and slowed repair. Tendons rely on tenocytes and tendon stem cells for maintenance. With age or overuse, NAD+ levels drop in these cells. This links to mitochondrial slowdown because NAD+ acts as a key coenzyme in energy production. Lower NAD+ can contribute to senescence in tendon stem cells, where cells stop dividing effectively and repair stalls. Oxidative stress rises, damaging collagen structure. Inflammation may persist or turn maladaptive, leading to disorganized tissue instead of clean regeneration. These layers mean breakdown outruns repair, keeping issues chronic rather than resolving.\\n\\n## Why NAD+ might help you\\n\\nIf your tendon issue involves cellular energy shortfalls, NAD+ precursors are discussed because they target repair pathways at the mitochondrial level. Step one: NAD+ supports sirtuin enzymes that regulate cell survival and stress resistance. Step two: Higher NAD+ may reduce oxidative damage in tendon cells by boosting antioxidant responses. Step three: This could allow better stem cell function and collagen organization instead of scar formation. Therefore for you: If that layer is part of your problem, NAD+ is discussed because it targets repair (tissue) — not because it masks pain.\\n\\n## How these fit together\\n\\nSingle-compound focus — NAD+ maps to the cellular energy layer in tendon degeneration. No siblings in scope here.\\n\\n## What the evidence actually shows\\n\\nHuman data: None exist for NAD+ or precursors like NR or NMN specifically in tendon conditions. General NAD+ boosting trials show safe increases in blood NAD+ levels in middle-aged adults, but no tendon outcomes measured. Preclinical data: One study found NMN reduced markers of oxidative stress and promoted SIRT expression in a tendinopathy model. Another noted lower NAD+ and","tokens_in":29027,"tokens_out":2583,"cost":0,"prev":"genesis","hash":"c18008dfdc350f2a3cd0380b12e6615f8e512621ac0e64815bcb8430d166e6e3"},{"ts":"2026-07-17T02:40:45.216Z","model":"owner","action":"voxel_divide","prompt":"","input":"nad-plus-tendon","response":"19 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"c18008dfdc350f2a3cd0380b12e6615f8e512621ac0e64815bcb8430d166e6e3","hash":"e4a05dd48ea6905a41b10de749040a16d7bc3d8a9bd3e12d2b92b68852be0ad7"}]}